Can GLP-1 Medicines Do More Than Weight Loss? What the Science Says About Pain

What are GLP-1s?

GLP-1 stands for “glucagon-like peptide-1.” It’s a hormone your body makes in the gut after you eat. It helps you feel full, slows how quickly food leaves your stomach, and balances blood sugar. Modern GLP-1 medicines copy that signal, which is why they work so well for weight and metabolic health.¹⁴

Why talk about GLP-1s and pain?

Pain is not just about injuries. It’s about how your whole body interprets signals. Our team often explains pain through this framework:

• Neuro (nervous system)
  
• Endocrine (hormones)
  
• Immune (inflammation)
  
• Energy (cell power and mitochondria)
  
• Sleep
  
• Gut
  
  

All of these systems talk to each other. When they’re out of balance, the “pain volume knob” can get stuck on high.

GLP-1s touch several of these systems. That’s why scientists are curious about their potential role in pain.

‍

How GLP-1s may turn the pain “volume knob”

1. The nervous system’s volume knob

Inside the spinal cord live immune-like cells called microglia. Think of them as the volume knob for your pain system.

• When they’re calm, the knob is set at a comfortable level.
  
• When they’re inflamed, the knob cranks up — and even small signals feel painfully loud.
  
  

Animal studies show that activating GLP-1 receptors on microglia helps dial the volume back down, sometimes by triggering the release of the body’s own natural pain relievers, like β-endorphins.²–⁵

2. The brain’s control center (the hypothalamus)

The hypothalamus is like your body’s command station for hunger, stress, hormones, and energy. GLP-1s can cross into this region with the help of “shuttle cells” called tanycytes.⁶ Once inside, GLP-1s may calm overactive circuits and reduce inflammation.⁷–⁹

3. The gut–brain–immune loop

GLP-1 comes from the gut, so it naturally plays in the gut–brain conversation. Research shows GLP-1 medicines reduce inflammatory signals in the body.⁷,¹⁰ Since many people with chronic pain also deal with gut problems or inflammation, this connection may help explain early findings. [Inference]

‍

What do human studies show so far?

The research is still early, but here’s what’s been seen in people:

• Knee osteoarthritis (OA): A large 2024 trial in The New England Journal of Medicine found semaglutide users not only lost more weight but also reported less knee pain and better function than placebo.¹ Was this just because of weight loss? Probably part of it. But the pain improvement was bigger than expected from weight loss alone.
  
• Migraine (pilot study): A 2025 prospective study in Headache tested liraglutide in people with obesity and frequent or chronic migraine. Over 12 weeks, monthly headache days dropped — even without significant weight change.¹¹ This hints at a more direct brain effect, but because the study was small and not blinded, it’s considered early evidence.
  
• Idiopathic intracranial hypertension (IIH): A 2023 randomized trial in Brain found exenatide lowered intracranial pressure within hours and reduced headache burden over 12 weeks.¹² IIH isn’t a common pain condition, but it shows GLP-1s may calm pressure and inflammation in the brain.
  
• Diabetic neuropathy (mixed): Some small studies found improvements in nerve health,¹³–¹⁵ while others didn’t. Overall, the evidence is inconsistent. More trials are needed.
  
  

What this means in plain terms

• For joint pain with excess weight, GLP-1s may help by reducing body weight and inflammation.
  
• For headache disorders like migraine or IIH, early research suggests brain pathways might also be involved.
  
• For nerve pain, the science isn’t clear yet.
  
  

Importantly, GLP-1s are not approved pain medicines. These findings are interesting and hopeful, but still at the research stage.

‍

What to keep in mind

GLP-1s have well-known side effects, especially nausea and GI upset. They also have serious safety warnings, including a boxed warning for thyroid C-cell tumors in rodents.¹⁶ Only a healthcare provider can help decide if they’re safe and appropriate for you.

‍

Why this excites us

GLP-1s may represent more than a new era of weight loss. They may open the door to rethinking pain through the lens of the gut, hormones, and inflammation. As pain specialists who have spent decades studying these systems, we see this as a frontier moment — where weight-loss medicine and pain science finally intersect. It’s time to expand the conversation from pounds lost to lives regained.

‍